Trial intelligence / Profile preview

SARP: Atorvastatin in Glomerular Disease

NCT00768638Phase 4Completed

Sponsor
Université Laval
Start
Oct 2008
Primary completion
May 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of atorvastatin in chronic kidney disease (CKD), sponsored by Université Laval. Started Oct 2008; status: completed.

02

Drugs

atorvastatin
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on NCT00768638.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00768638.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call